InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,466.09
(
-0.13%
)
US TECH 100
19,179.20
(
-0.41%
)
Dow Jones
39,204.71
(
0.18%
)
Brent Oil
85.16
(
0.18%
)
Bitcoin
63,717.42
(
-1.70%
)
Post# of 252283
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 119885
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 143763

Wednesday, 06/13/2012 1:04:28 PM

Wednesday, June 13, 2012 1:04:28 PM

Post# of 252283
REGN—Where do you see any suggestion that Roche would seek to sell Fovista only in combination with Lucentis? Something like that has never been done with biologics, as far as I know, and it would encounter practical problems apart from the anti-competitive legal issues.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up